E1	Eq-Comparison:T1 Operator:T33 Value:T34 Temporal-Unit:T35
E2	Age:T2 Numeric-Filter:E1
E4	Condition:T4 Name:T36
E5	Eq-Comparison:T5 Value:T54 Operator:T55 Value2:T56
E9	Negation:T9 Negates:E10
E10	Condition:T10 Name:T38
E13	Negation:T13 Negates:E15
E14	Eq-Comparison:T14 Temporal-Period:T40
E15	Condition:T15 Name:T41 Temporality:E14
E16	Negation:T16 Negates:E8
E18	Negation:T18 Negates:E12
E19	Eq-Comparison:T19 Temporal-Period:T43
E20	Drug:T20 Name:T44
E21	Assertion:T21 Asserted:E22
E22	Drug:T22 Name:T45
E23	Assertion:T23 Asserted:E17
E24	Eq-Comparison:T24 Temporal-Period:T46
E25	Procedure:T25 Temporality:E24
E26	Drug:T26 Name:T47 Stability:T48
E27	Negation:T27 Negates:E34
E28	Eq-Comparison:T28 Temporal-Period:T49
E29	Drug:T29 Name:T51
E30	Negation:T30 Negates:T59
E31	Condition:T31 Name:T52
E32	Death:T32 
E33	Coreference:T53 Refers-To:E4 Stage:E5
E6	Modifier:T6 Modifies:E33
E7	Eq-Comparison:T7 Temporal-Period:T8
E8	Observation:T12 Name:T42 Polarity:T17
E12	Condition:T37 Name:T39 Temporality:E19
E17	Study:T58 
E34	Procedure:T50 Temporality:E28
E36	Assertion:T60 Asserted:E30
E37	Drug:T61 
T1	Eq-Comparison 34 47	over 60 years
T2	Age 51 54	age
T4	Condition 84 103	Parkinson's disease
T5	Eq-Comparison 131 134	2-3
T9	Negation 158 161	Not
T10	Condition 162 180	exposed to tobacco
T13	Negation 217 219	No
T14	Eq-Comparison 220 227	history
T15	Condition 231 244	lung diseases
T16	Negation 250 252	No
T18	Negation 283 285	No
T19	Eq-Comparison 286 293	history
T20	Drug 318 326	nicotine
T21	Assertion 332 339	Able to
T22	Drug 344 364	nicotine nasal spray
T23	Assertion 395 402	able to
T24	Eq-Comparison 431 444	Under current
T25	Procedure 445 454	treatment
T26	Drug 460 468	levodopa
T27	Negation 491 494	Not
T28	Eq-Comparison 495 514	currently receiving
T29	Drug 517 544	monoamine oxidase inhibitor
T30	Negation 579 585	Unable
T31	Condition 627 643	adverse reaction
T32	Death 649 654	Death
T33	Eq-Operator 34 38	over
T34	Eq-Value 39 41	60
T35	Eq-Temporal-Unit 42 47	years
T36	Condition-Name 84 103	Parkinson's disease
T38	Condition-Name 162 180	exposed to tobacco
T40	Eq-Temporal-Period 220 227	history
T41	Condition-Name 231 244	lung diseases
T42	Observation-Name 253 263	laboratory
T43	Eq-Temporal-Period 286 293	history
T44	Drug-Name 318 326	nicotine
T45	Drug-Name 344 364	nicotine nasal spray
T46	Eq-Temporal-Period 431 444	Under current
T47	Drug-Name 460 468	levodopa
T48	Stability 474 480	stable
T49	Eq-Temporal-Period 495 514	currently receiving
T51	Drug-Name 517 544	monoamine oxidase inhibitor
T52	Condition-Name 627 643	adverse reaction
T53	Coreference 119 130	the disease
T54	Eq-Value 131 132	2
T55	Eq-Operator 132 133	-
T56	Eq-Value 133 134	3
T6	Modifier 138 152	Hoehn and Yahr
T7	Eq-Comparison 188 211	any stage of their life
T8	Eq-Temporal-Period 188 211	any stage of their life
T12	Observation 253 263	laboratory
T17	Polarity 264 277	abnormalities
T37	Condition 297 314	adverse reactions
T39	Condition-Name 297 314	adverse reactions
T57	Location 383 394	Mexico City
T58	Study 414 425	evaluations
T50	Procedure 545 554	treatment
T59	Encounter 598 607	follow-up
T60	Assertion 579 585	Unable
T61	Drug 622 626	Drug
A2	Assertion-Type-Value E21 hypothetical
A3	Assertion-Type-Value E23 hypothetical
A4	Eq-Operator-Value T33 GT
A5	Eq-Temporal-Unit-Value T35 year
A6	Eq-Temporal-Period-Value T40 past
A7	Eq-Temporal-Period-Value T43 past
A8	Eq-Temporal-Period-Value T46 present
A9	Stability-Value T48 stable
A10	Eq-Temporal-Period-Value T49 present
A12	Eq-Operator-Value T55 BETWEEN
A13	Eq-Temporal-Period-Value T8 anytime
A14	Observation-Type-Value E8 lab
A15	Polarity-Value T17 abnormal
A16	Location-Value T57 residence
A11	Assertion-Type-Value E36 hypothetical
R1	Caused-By Arg1:E12 Arg2:E20
R2	Using Arg1:E25 Arg2:E26
R3	Using Arg1:E34 Arg2:E29
R4	Caused-By Arg1:E31 Arg2:E37
R5	And Arg1:E2 Arg2:E4
R6	During Arg1:E10 Arg2:E7
